Greene v. Abbott Laboratories

137 Misc. 2d 424, 521 N.Y.S.2d 382, 1987 N.Y. Misc. LEXIS 2644
New York Supreme Court·Decided November 6, 1987·Published·Cited by 2 cases

Opinion

OPINION OF THE COURT

Ira Gammerman, J.

Defendants (E. R. Squibb & Sons, Abbott Laboratories, Merck & Co., The Upjohn Company and Eli Lilly & Company) move pursuant to CPLR 3211 (a) (5) and/or 3212 for partial summary judgment dismissing plaintiffs wrongful death claims as barred by the Statute of Limitations.

Plaintiff, as administrator of the estate of his deceased daughter, Susan Greene, relies on the revival statute (L 1986, ch 682, § 4)

Free access — add to your briefcase to read the full text and ask questions with AI

Greene v. Abbott Laboratories, 137 Misc. 2d 424, 521 N.Y.S.2d 382, 1987 N.Y. Misc. LEXIS 2644 (N.Y. Super. Ct. 1987).

137 Misc. 2d 424 (Greene v. Abbott Laboratories) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Monte v. National Gypsum Company
921 F.2d 405 (Second Circuit, 1990)
Monte v. National Gypsum Co.
921 F.2d 405 (Second Circuit, 1990)